{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07843",
      "entity_text" : "IFX trough",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellType" : [ "cl:CL:0002062" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Early studies suggested a potential therapeutic benefit to combination therapy (CT) utilizing both IFX and IM, mainly through reduction of antibodies to IFX (ATI), reduced infusion reactions and higher IFX trough levels [XREF_BIBR].",
  "reading_complete" : "2020-08-08T18:40:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T18:38:38Z",
  "trigger" : "levels",
  "evidence" : [ "IFX trough levels" ],
  "pmc_id" : "5797978",
  "score" : 0
}